Approval of Diamyd’s Diabetes Vaccine Set for 2011

Approval of Diamyd’s Diabetes Vaccine Set for 2011: The diabetes vaccine being developing by Diamyd is not far from being approved. Diamyd is using two different technologies: the first is based on a GAD65 molecule. The molecule was shown to stall the destruction of beta cells connected with Type 1 diabetes. The other technology involves a system to deliver substances directly to nerve cells. A parallel phase III trial will be performed in Europe in 2011.